Quantitation in PET using isotopes emitting prompt single gammas: application to yttrium-86
- 17 December 2002
- journal article
- research article
- Published by Springer Nature in European Journal of Nuclear Medicine and Molecular Imaging
- Vol. 30 (3) , 354-361
- https://doi.org/10.1007/s00259-002-1068-y
Abstract
Several yttrium-90 labelled somatostatin analogues are now available for cancer radiotherapy. After injection, a large amount of the compound is excreted via the urinary tract, while a variable part is trapped in the tumour(s), allowing the curative effect. Unfortunately, the compound may also be trapped in critical tissues such as kidney or bone marrow. As a consequence, a method for assessment of individual biodistribution and pharmacokinetics is required to predict the maximum dose that can be safely injected into patients. However, 90Y, a pure β–particle emitter, cannot be used for quantitative imaging. Yttrium-86 is a positron emitter that allows imaging of tissue uptake using a PET camera. In addition to the positron, 86Y also emits a multitude of prompt single γ-rays, leading to significant overestimation of uptake when using classical reconstruction methods. We propose a patient-dependent correction method based on sinogram tail fitting using an 86Y point spread function library. When applied to abdominal phantom acquisition data, the proposed correction method significantly improved the accuracy of the quantification: the initial overestimation of background activity by 117% was reduced to 9%, while the initial error in respect of kidney uptake by 84% was reduced to 5%. In patient studies, the mean discrepancy between PET total body activity and the activity expected from urinary collections was reduced from 92% to 7%, showing the benefit of the proposed correction method.Keywords
This publication has 15 references indexed in Scilit:
- Somatostatin receptor-targeted radionuclide therapy of tumors: Preclinical and clinical findingsSeminars in Nuclear Medicine, 2002
- Preliminary data on biodistribution and dosimetry for therapy planning of somatostatin receptor positive tumours: comparison of 86Y-DOTATOC and 111In-DTPA-octreotideEuropean Journal of Nuclear Medicine and Molecular Imaging, 2001
- Uptake kinetics of the somatostatin receptor ligand [ 86 Y]DOTA- d Phe 1 -Tyr 3 -octreotide ([ 86 Y]SMT487) using positron emission tomography in non-human primates and calculation of radiation doses of the 90 Y-labelled analogueEuropean Journal of Nuclear Medicine and Molecular Imaging, 1999
- Alternative positron emission tomography with non-conventional positron emitters: effects of their physical properties on image quality and potential clinical applicationsEuropean Journal of Nuclear Medicine and Molecular Imaging, 1997
- Nuclear Data Sheets for A = 86Nuclear Data Sheets, 1997
- Radiation doses of yttrium-90 citrate and yttrium-90 EDTMP as determined via analogous yttrium-86 complexes and positron emission tomographyEuropean Journal of Nuclear Medicine and Molecular Imaging, 1996
- Quantitative PET with positron emitters that emit prompt gamma raysIEEE Transactions on Medical Imaging, 1995
- The ECAT EXACT HRJournal of Computer Assisted Tomography, 1994
- Accelerated image reconstruction using ordered subsets of projection dataIEEE Transactions on Medical Imaging, 1994
- Production of the positron emitting radioisotope 86Y for nuclear medical applicationApplied Radiation and Isotopes, 1993